State Key Laboratory of Cardiology, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Pharmacol Res. 2024 Jul;205:107256. doi: 10.1016/j.phrs.2024.107256. Epub 2024 Jun 10.
Inflammation is a crucial factor in cardiac remodeling after acute myocardial infarction (MI). Neutrophils, as the first wave of leukocytes to infiltrate the injured myocardium, exacerbate inflammation and cardiac injury. However, therapies that deplete neutrophils to manage cardiac remodeling after MI have not consistently produced promising outcomes. Recent studies have revealed that neutrophils at different time points and locations may have distinct functions. Thus, transferring neutrophil phenotypes, rather than simply blocking their activities, potentially meet the needs of cardiac repair. In this review, we focus on discussing the fate, heterogeneity, functions of neutrophils, and attempt to provide a more comprehensive understanding of their roles and targeting strategies in MI. We highlight the strategies and translational potential of targeting neutrophils to limit cardiac injury to reduce morbidity and mortality from MI.
炎症是急性心肌梗死(MI)后心肌重构的关键因素。中性粒细胞作为浸润损伤心肌的第一波白细胞,会加剧炎症和心脏损伤。然而,耗竭中性粒细胞以管理 MI 后心脏重构的治疗方法并未始终产生理想的结果。最近的研究表明,不同时间点和位置的中性粒细胞可能具有不同的功能。因此,改变中性粒细胞表型,而不是简单地阻止其活性,可能更符合心脏修复的需求。在这篇综述中,我们重点讨论了中性粒细胞的命运、异质性、功能,并试图更全面地了解它们在 MI 中的作用和靶向策略。我们强调了靶向中性粒细胞以限制心脏损伤从而降低 MI 发病率和死亡率的策略和转化潜力。